Carboplatinum

DRUG2 trials

Sponsors

Gradalis, Inc., AZ-VUB

Conditions

Breast CancerStage III Ovarian CancerStage IV Ovarian Cancer

Phase 2

Salvage Ovarian FANG™ Vaccine + Carboplatinum

CompletedNCT01867086

Gradalis, Inc.Stage III Ovarian Cancer, Stage IV Ovarian Cancer

Start: 2013-06-30End: 2016-04-08Updated: 2018-06-19

Phase II Study of Neoadjuvant Weekly Paclitaxel and Carboplatin Followed by Dose Dense Epirubicin and Cyclophosphamide in Stage II and III Triple Negative Breast Cancer

CompletedNCT04224922

AZ-VUBBreast Cancer

Start: 2015-05-31End: 2017-05-31Updated: 2020-01-18

Related Papers

New advances in cancer therapy targeting TGF-β signaling pathways

Molecular Therapy — Oncolytics2023-12-0127 citations

Survival effect of bi-shRNA<sup>furin</sup>/GMCSF DNA-based immunotherapy (FANG) in 123 advanced cancer patients to α-interferon-ELISPTOT response.

Journal of Clinical Oncology2014-05-202 citations